Cannabis Cures Cancer

"In California, approximately 133,000 people
are diagnosed every year with some form of invasive
cancer, not including the common skin
cancers. About 53,000 Californians die each
year from cancer."

Help free the cure, inform others, save lives.

To treat cancer it takes about 90 gram's of high quality cannabis oil ... Patients should take 1/3 of a gram of oil 3 times a day ... It takes about 1lb of high quality cannabis flowers to be able to make enough oil for one treatment ...
Start off slow and work your dosage up

One healthy large indoor or outdoor plant can produce 1lb of cannabis in a 90 day growth cycle. If possible grow your own to avoid cannabis contaminated with pesticides. One LB of Cannabis should make enough oil (90-100g) for 90 days ...

Make your own oil to cure your CANCER !!!

This blog is to help inform the public on the truth and medical benefits of cannabis. It also contains info to help teach others the healthiest and safest way to grow or acquire their medicine, what strains are best for their condition and responsible and healthy ways of medicating.

Have suggestions, comments, or questions you can email me at

Storm Crows MMJ Cannabis List on all ailments

Skunk Farm Oil Technique

"Note some solvents are cleaner than others"
AKA 100% Food Grade Ethanol, or Food grade Alcohol.

How to make cannabis milk
Make it into ice-cream to help with taste

Find us on You Tube

California Prop 215 Sb 420 & your patients rights .doc


Run for the cure video links; Cancer stopping cannabis extracts and one mans story.

You tube link to 7 part series

Article about "Run For the Cure" and easy video links

Here is some very good books on how to test for CBD's and the making of pure oil.
Marijuana Chemistry

Cannabis Chemistry

Cannabis Medical Extracts

THC / CBD / ETC Test Kits

MMJ Instructions

Cannabis Oil (QWISO)

Cannabis Milk

Bubble Hash


Coconut Oil

Juicing Raw Buds

DMSO for oil topical pain relief

Mix 50% rso 40% olive oil and 10% DMSO at luke warm ...

Links to learn how to grow your own ... It is easy cost effective and provides pesticide free medication.


Monday, August 11, 2008

Friday, July 25, 2008

How to make Cannabis Milk

This is copied from Marijuana Saves Lives
Lactose Free Cannabis Milk

Needed Ingredients

4 quarts goats milk ( If lactose is wanted...use Cows milk)
2 tbs goat milk butter (get European style goat milk butter since it has a higher fat content)

1 to 3 ounces trim or buds

anywhere from 1 oz of good sugar trim or buds to 3 oz. or more if you like it to be really potent...then also you can vary the strain for different effects. A strong sativa can make a great day time or morning....

Indica for pain or sleep and so on..

Note: If the Milk containers are plastic then save them to pour the milk back into them for storage in the fridge... A sealed container would be best for the milk for preservation.

The best method yet I have found is using a pressure cooker. put the ingredients listed above and place them into the pressure cooker and soak for 4 days in the refrigerator stirring everyday then placing it back into the fridge.... on the 4th day take the pressure cooker out of the fridge and place on the stove on low temp.

Make sure the dial is almost as low as the dial can turn.

Then let it warm up...... after it is warm almost hot start the 4 hour timer.

make sure it does not boil or even simmer for that do not want it to get to hot....The heat will degenerate the medicinal properties... I think I remember hearing cannabinoids degenerate after 200 degrees F ....but please do not quote me on that....

After 4 hours when the timer has gone off, strain out the milk and press out the milk from the material in the strainer. Pour milk into the container then let the milk cool then place into the fridge...

You're done... Very Strong Do Not Drive

Monday, July 21, 2008

BHANG LASSI; Traditional Medicinal Indian Drink

In India cannabis leaves and milk are made into extracts known as Bhang.
Bhang is used often to make drinks with a buzz , such as traditional lassi.

So lets begin ;)
1 cup of high fat milk or goats milk
1 gram to 4 grams of powdered sinsemilla flowers
F or best results cook this in a pressure cooker for 30 minutes or more, so the milk does not curdle. You can also strain out the cannabis with a cheese cloth)
Now Add;
2-3 Tablespoons of Natural Sugar
1/2 cardamom (get this spice at India grocery stores )
1 teaspoon Rose water :p
a dash of cinnamon, nutmeg , or clove ( your choice)
Heat to near boiling, Simmer 30 min. or more

Cool & Strain.

Mix in :
2 cups of Natural Organic Yogurt (plain)
Serves : 2

Very Medicinal DO NOT DRIVE !!!!!

Friday, May 23, 2008

Medical marijuana bill heads to Assembly floor

Today, MPP-sponsored legislation that would direct California's state and local law enforcement agencies not to assist in federal raids on medical marijuana patients and their caregivers made significant progress in the state legislature. In a 9-7 vote, the Committee on Appropriations approved A.B. 2743, sending it to the floor for a final vote of the entire state Assembly.

Please help us pass this important bill by e-mailing your state Assembly member today.

Taking action is easy. Just visit MPP's action page, enter your information, and send an e-mail to your legislator. If you are a patient or medical professional, please modify the message to include that information.

If approved, A.B. 2743 — authored by Assembly Member Lori Saldaña (D-San Diego) — will dramatically improve protections for California's medical marijuana patients and providers.

Most federal raids on California's medical marijuana facilities rely on significant help from local law enforcement agencies; in many cases, local agents have even asked federal agents to raid patients and providers. A.B. 2743 will create a policy of respecting the state's protections for medical marijuana patients and their providers.

Passage of this landmark bill will not be possible without your participation. Making contact with state policy-makers is one of the most effective ways to help change the laws.

Thank you for taking action to support our state's right to self-determination and safe access to medical marijuana for seriously ill and injured patients.

According to our records, you are not yet signed up for MPP’s California e-mail alerts. Please consider subscribing now so that you can keep abreast of the progress of this bill and our other efforts in California.

To sign up for state-specific alerts, click here, fill out the required fields, and make sure that you select the option for California alerts. You can also simply reply to this e-mail with "subscribe" in the body.

Please don't forget to forward this message on to friends, family, and co-workers in California, so that they too can take action.


Aaron Smith
California Organizer
Marijuana Policy Project

Tuesday, May 13, 2008

THC Kill's Cancer !!! Shrinks Tumors

Watch THC Kill Cancer in less than 20 hours

The major active component of the medicinal plant cannabis, Δ9-THC, has been shown in experiments with rats to have therapeutic potential against brain tumors. SETH Group scientists Garret Yount, Ph.D. and Sean McAllister, Ph.D. designed experiments in a time-lapse microscope to test whether Δ9-THC can stop the growth of human glioblastoma multiforma (GBM) brain cancer cells. Using the same tests that are used to judge new chemotherapies, the team discovered that the herbal compound kills human GBM cells at a concentration that is nontoxic to normal brain cells. Click here to see Featured Experiment.

Cannabis shrinks Tumors, the Government knew in 1974

Wednesday, May 7, 2008

Are Humans CBD Defficaint?

I can’t help by think that all humans are Cannabinoids deficient, and this is what leads to sickness, cancers and tumors. Cannabinoids help regulate the immune system, and when they are not present, the body is not able to fight off the modern chemicals and toxins in our body. In an article on Treating Yourself magazine, it shows how Cannabinoids can help inhibit the bird flu. This is the reason why it is illegal; it is a medication better than anything on the market and can help almost all conditions.

Helps Arthritis Patients

Friday, May 2, 2008


Get your prescription

The Goverment wants people to suffer; In Pot We Trust; Why they won't pass the MMJ Protection Act.

The Republicans are unanimously against cannabis except for a few patriots such as Ron Paul, please vote Democrat this year for the good of our country.
50% CBD (Stops Cancer, Tumors, Autoimmune Diseases)
50% THC Stops the pain.
Please write and pressure Congress to get this drug approved in the US!!

Here is some very good books on how to test for CBD's and the making of pure oil.
Marijuana Chemistry

Cannabis Chemistry

Cannabis Medical Extracts

Thursday, May 1, 2008

Write to Congress !!!!!

Dear Freedom Grower

Thank you for contacting me in support of more sensible drug laws. I appreciate the time you took to share your thoughts, and I agree with you.

I agree that our current policy regarding non-violent drug offenders is not working. In addition to supporting states' rights to medical marijuana, I also believe that treatment, not incarceration, is the proper way to handle non-violent drug users. Incarceration for these recreational drug users is inefficient and ineffective. You may be interested to know that I have also consistently opposed mandatory minimum sentencing, which is often applied to non-violent drug offenders. Should any legislation come before the full House of Representatives for a vote, I will be sure to keep your views in mind.

Again, thanks for being in touch. If I may be of assistance to you or your family, please don't hesitate to contact me.


Zoe Lofgren

Member of Congress

Wednesday, April 30, 2008

Distractions in Society

*Lacking of Education.
*Lacking of acceptance of ideas and people, you’re individual FREEDOM, what our forefathers fought for.
*The widespread infatuation with Media, Sex, Drugs, Money, and Greed.
*Corporations are corrupting the government for profit, hoarding profits, and bringing down the lower and middle class standards. They are slowly driving our economy down and causing inflation on food and gas prices. They have also put our young citizens at risk in a war they know they can not win for the profits of defense and oil corporations. Some politicians wish for a North American Union and are trying to lower the middle and lower class standards for Americans to meet that of other counties.

The problem is people don’t care, are distracted, and uneducated. The media has been taken over by corporations, and is putting fear and pushing for more government control in our society. Our society has become to content.

The medical industry wants to make money off of dying people instead of curing them? Is this in the public’s interest? They use money donated to Research Company’s to push for more and new drugs for increased profit margins.The government stops real research like genetic and stem cell research, in the name of God and religion, but our forefathers made that definitely separated in our constitution.

Speak up for your rights, and free speech, do you really want to become slaves?

Spread the word;

LSD Doc, Inventor, Creator, Dies

Monday, April 28, 2008

Comical Video on Cannabis Effects;

Determined to find out the true effects of marijuana on the human body, stand-up comedian and former Stoner of the Year Doug Benson documents his experience avoiding pot for 30 days and then consuming massive amounts of the drug for 30 days. More than just an amusing story of one man's quest to get superhigh, this documentary also examines the hotly contested debate over medical marijuana use.

Friday, April 18, 2008

Medical Marijuana Patient Protection Act Introduced Yesterday in Congress

Medical Marijuana Patient Protection Act Introduced Yesterday in Congress


Americans for Safe Access
For Immediate Release:* April 18, 2008

*Medical Marijuana Patient Protection Act Introduced Yesterday in Congress */HR 5842 would reschedule marijuana for medical use, end federal
interference in state laws/

*Washington, D.C. *-- Congressional Representative Barney Frank (D-MA)
introduced the "Medical Marijuana Patient Protection Act," HR 5842,
yesterday, a bill co-sponsored by Representatives Maurice Hinchey
(D-NY), Sam Farr (D-CA), Dana Rohrabacher (R-CA), and Ron Paul (R-TX).
The act would change federal policy on medical marijuana in a number of
ways. Specifically, HR 5842 would reclassify marijuana from a Schedule I
drug, which cannot be prescribed, to a Schedule II drug, which would
recognize the medical value of marijuana and create a regulatory
framework for the FDA to begin a drug approval process for marijuana.
The act would also prevent interference by the federal government in any
local or state run medical marijuana program.

Similar versions of HR 5842 have been introduced in prior Congressional
terms, but have never made it out of committee. "It's time that the
federal government take this issue seriously," said Caren Woodson,
Government Affairs Director with Americans for Safe Access (ASA), a
nationwide medical marijuana advocacy group working with Mr. Frank and
other Members of Congress to change federal policy. "By disregarding
marijuana's medical efficacy, and undermining efforts to implement state
laws, the federal government is willfully placing hundreds of thousands
of sick Americans in harms way."

In addition to rescheduling marijuana under the Controlled Substances
Act (CSA), HR 5842 would provide protection from the CSA and the federal
Food, Drug, and Cosmetic Act (FDCA) for qualified patients and
caregivers in states that have legalized the use of medical marijuana.
Specifically, the act prevents the CSA and FDCA from prohibiting or
restricting: (1) a physician from prescribing or recommending marijuana
for medical use, (2) an individual from obtaining, possessing,
transporting within their state, manufacturing, or using marijuana in
accordance with their state law, (3) an individual authorized under
State law from obtaining, possessing, transporting within their state,
or manufacturing marijuana on behalf of an authorized patient, or (4) an
entity authorized under local or State law to distribute medical
marijuana to authorized patients from obtaining, possessing, or
distributing marijuana to such authorized patients.

In December, U.S. House Judiciary Chair John Conyers stated publicly his
concern about the tactics being used by the Drug Enforcement
Administration (DEA) and promised oversight hearings. Since then,
several California mayors have written to Conyers expressing their
support for hearings, including the mayors of San Francisco, Oakland,
West Hollywood, and Santa Cruz. Opposition to federal interference in
state medical marijuana laws has also come from multiple city councils,
members of the California Board of Equalization and the state
legislature, as well as New Mexico Governor Bill Richardson.

Further information:
Medical Marijuana Patient Protection Act, HR 5842:
ASA Fact Sheet on the Escalation of Harmful DEA Tactics:
December 2007 Statement by House Judiciary Chair John Conyers:
Letter from San Francisco Mayor Gavin Newsom to Conyers:
Letter from NM Governor Richardson to President GW Bush:

# # #

With over 30,000 active members in more than 40 states, Americans for
Safe Access (ASA) is the largest national member-based organization of
patients, medical professionals, scientists and concerned citizens
promoting safe and legal access to cannabis for therapeutic use and
research. ASA works to overcome political and legal barriers by creating
policies that improve access to medical cannabis for patients and
researchers through legislation, education, litigation, grassroots
actions, advocacy and services for patients and the caregivers.

Tuesday, April 15, 2008

April 20, 2008 "Bay Area" Fun

Monday, March 17, 2008

Cannabis Medical Articles & Studies

Highlights of the Studies (

New Mexico: This study involved 250 patients.The study compared marijuana to THC capsules. The research protocol was approved by the FDA in 1978. In order to participate in the research the patient had to be referred by a physician and had to have failed on at least three other antiemetics. Patients were permitted to choose marijuana or the THC pill.

Both objective (e.g., frequency of vomiting, amount of vomiting, muscle biofeedback, blood samples and patient observation) and subjective measures were made to determine the effectiveness of the drug.

The study concluded that marijuana was not only an effective antiemetic but also far superior to the best available conventional drug, Compazine, and clearly superior to synthetic THC pill." The study found that [m]ore than [90] percent of the patients who received marijuana . . . reported significant or total relief from nausea and vomiting." The study found no major adverse side effects. Only three patients reported adverse reactions, none of these reactions involved marijuana alone. The 1984 report concluded . . . the data accumulated over all five years of the program's operation do show that marijuana smoked resulted in a higher percentage of success than does THC ingested."

California: California conducted a series of studies from 1981 through 1989. Annual reports were submitted to the FDA, state legislature and Governor. Each year approximately 90 to 100 patients received marijuana. The California research was described as a Phase III trial."

The study protocol preferred THC pills by making it much easier for patients to enter that portion of the study. Patients who received marijuana had to be over 15 years of age (the THC pill patients had to be over 5 years of age); had to be marijuana experienced, use the drug on an in-patient basis (patients could only use marijuana in the hospital and not take the medicine home) and had to be receiving rarely used and severe forms of chemotherapy. Thus, the design of the study did not favor marijuana.

Even with this built in bias against marijuana, the study consistently found marijuana to be an effective antiemetic. In 1981 the California Research Advisory Panel reported: "Over 74 percent of the cancer patients treated in the program have reported that marijuana is more effective in relieving their nausea and vomiting than any other drug they have tried." In 1982, a 78.9 percent effectiveness rate was found for smoked marijuana. By 1983 the report was conclusory in its findings stating:

The California Program also has met its research objectives. Marijuana has been shown to be effective for many cancer chemotherapy patients, safe dosage levels have been established and a dosage regimen which minimizes undesirable side effects has been devised and tested.

The California Research Advisory Panel continued to review data on marijuana until 1989 with similar results.

Michigan: The Michigan research compared marijuana to Torecan. It involved 165 patients. Upon admission to the program patients were randomized into control groups with some randomized on the conventional antiemetic Torecan and the remainder randomized to marijuana. When failure on the initial randomized drug occurred, patients could elect to crossover to the alternate therapy. This procedure allowed the Michigan Department of Health to evaluate how well patients responded to both drugs and allowed patients to register their preference.

The Michigan study reported 71.1 percent of the patients who received marijuana reported no emesis to moderate nausea. Ninety percent of the patients receiving marijuana elected to remain on marijuana. Only 8 of 83 patients randomized to marijuana chose to alter their mode of antiemetic therapy. This was almost the inverse of patients randomized to Torecan, there more than 90 percent - 22 out of 23 patients - elected to discontinue use of Torecan and switched to marijuana.

Very few serious side effects were found related to marijuana use. The most common side effect was increased appetite - reported by 32.3 percent of patients - this was a positive effect. The most common negative effects were sleepiness, reported by 21 patients and sore throat, reported by 13 patients.

Tennessee: This study involved an evaluation of 27 patients. The patients had all failed on other forms of antiemetic therapy including oral THC. The study found an overall success rate of 90.4 percent for marijuana inhalation therapy. In comparison it found a 66.7 percent success rate for THC capsules. In the under 40 age group, the study found a 100 percent success rate for marijuana inhalation therapy.

The report concludes:

We found both marijuana smoking and THC capsules to be effective anti-emetics. We found an approximate 23 percent higher success rate among those patients administered THC capsules. We found no significant differences in success rates by age group. We found that the major reason for smoking failure was smoking intolerance; while the major reason for THC capsule failure was nausea and vomiting so severe that patient could not retain the capsule.

New York: In describing the purpose of the marijuana research program the New York Department of Health stated: [t]he program is a large-scale (Phase III) cooperative clinical trial . . . ." The central question addressed is [h]ow effective is inhalation marijuana in preventing nausea and vomiting due to chemotherapy in patients . . . who have failed to respond to previous antiemetic therapy?"

By 1985, the New York program had extended marijuana therapy to 208 patients through 55 practitioners. Of that, 199 patients were evaluated. These patients had received a total of 6,044 NIDA-supplied marijuana cigarettes which were provided to patients during 514 treatment episodes.

In percentage terms the results were stunning:

* North Shore Hospital reported marijuana was effective at reducing emesis 92.9 percent of the time;
* Columbia Memorial Hospital reported efficacy of 89.7 percent;
* Upstate Medical Center, St. Joseph's Hospital and Jamestown General Hospital reported 100 percent of the patients smoking marijuana gained significant benefit.

The report concludes: "Patient evaluations have indicated that approximately ninety-three (93) percent of marijuana inhalation treatment episodes are reported to be effective' or highly effective' when compared to other antiemetics." The New York study reports no serious adverse side effects. No patient receiving marijuana required hospitalization or any other form of medical intervention. See, Evaluation of the Antiemetic Properties of Inhalation Marijuana in Cancer Patients Receiving Chemotherapy Treatment," New York Department of Health, Office of Public Health (Annual Reports).

Georgia: The Georgia program evaluated 119 patients. It compared THC to standardized smoking of marijuana and with patient-controlled smoking. To enter the program a patient had to have failed on other antiemetics. Patients were randomized to either patient-controlled smoking of marijuana, standardized smoking of marijuana or THC pills.

The report found that both THC and marijuana were effective in providing antiemetic relief for patients who were previously unresponsive to antiemetics. The rate of success was 73.1 percent. Patient controlled smoking of marijuana was successful in 72.2 percent, standardized smoking was successful in 65.4 percent and THC was effective in 76 percent of the cases. In comparing the reasons for failure between marijuana and THC the report found:

The primary reasons for failure of THC capsules were due to either adverse reaction (6 out of 18) or failure to improve nausea and vomiting (9 out of 18). The primary reason for failure of smoking marijuana were due to smoking intolerance (6 out of 14) or failure to improve the nausea and vomiting (3 out of 14).

Beaconsfield, D., Ginsburg, J., and Rainsbury, R. (1973). Therapeutic potential of marihuana. New Eng. J. Medicine 289, 1315.

Therapeutic Aspects. 1974. Marijuana and Health, Fourth Annual Report to the U.S. Congress, Nat'l Institute on Drug Abuse, 134-143.

Therapeutic Aspects. 1975. Marijuana and Health, Fifth Annual Report to the U.S. Congress, Nat'l Institute on Drug Abuse, 117-132.

Bhargave, H. (1978). Potential therapeutic application of naturally occurring and synthetic cannabinoids. Gen. Pharmac., 9, 195-213.

Ungerleider, J. (1979). Marijuana as a good medicine: Its uses against disease. Lecture delivered to UCLA Center for the Health Sciences, August 21, 1979.

Zinberg, N. (1979). On cannabis and health. J. Psychedelic Drugs, 11, 135-144.

AMA Council on Scientific Affairs. (1980). Marihuana reexamined: Pulmonary risks and therapeutic potentials. Conn. Medicine, 44, 521-523. Cohen, S. (1980). Therapeutic aspects. Nat'l Inst. Drug Abuse. Res. Mono. Ser., No. 31, 199-216.

Council on Scientific Affairs. (1981). Marijuana: Its health hazards and therapeutic potentials. JAMA, 246, 1823-1827.

DuQuesne, J. (1981). Cannabis and the Rule of Law. Lancet, Sept. 12, 1981, 581.

Rose, M. (1981). Cannabis and the rule of law. Lancet, July 18, 1981.

Therapeutic potential and medical uses of marijuana. (1982). In Marijuana and Health, Inst. of Medicine, 139-155.

Schurr, A. (1985). Marijuana: Much ado about THC. Comp. Biochem. Physiol., 80 C, 1-7.

Ungerleider, J. and Andrysiak, T. (1985). Therapeutic issues of marijuana and THC., Int'l J. Addictions, 20, 691-699.

Grinspoon, L. and Bakalar, J., (1995). Marihuana as Medicine, A Plea for Reconsideration, JAMA, 273: 1875-1876.

Medical Marijuana and Nausea, Vomiting and Appetite

Hollister, L (1970) Hunger and appetite after single doses of marihuana, alcohol and dextroamphetamine. Clin. Pharmacol. and Therapeutics, 12, 44-49.

Sallan, S.E., Zinberg, N.E., Ferei, E., III, (1975), Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N. Eng. J.Med., 293, 795-797.

Greenberg, I., Kuehnle, J., Mendelson,J.H. and Bernstein, J.G. 1976. Effects of marihuana use on body weight and caloric intake in human. Journal of Psychopharmacology (Berlin) 49: 79-84.

Harris, L. (1976). Analgesic and antitumor potential of the cannabinoids. In Therapeutic Potential of Marijuana. (Cohen and Stillman, eds., 299-309.

Harris, L. Munson, A. and Carchman, R. (1976). Antitumor properties of

cannabinoids. In The Pharmacology of Marihuana (Braude and Szara, eds.), 749-762.

Chang, A. et al. (1979). Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. Annals of Internal Medicine, 91, 819-824.

Sallan, S.E., Cronin, C. Zelen, M., Zinberg, N.E. (1980). Antiemetics in patients receiving chemotherapy for cancer. A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N. Engl. J. Med., 302: 135-8.

California State Reports, Therapeutic Cannabis Program, Annual Report to the Governor and Legislature, California Research Advisory Panel (1980-1986).

Bateman, D.C., Rawlins, M. (1982). Therapeutic potential of cannabinoids. Br. Med. J., 284, 1211-1212.

Cannabinoids for nausea, (1981). Lancet, Jan. 31, 1981, 255-256.

Frytek, S., Moertel, C.G., (1981), Management of nausea and vomiting in the cancer patient, JAMA, 245, 394-396.

Neidhart, J., Gagen, M., Wilson, H. and Young, D. (1981). Comparative trial of the antiemetic effects of THC and haloperidol. J. Clin. Pharmacol., 21, 385-425.

Michigan Department of Public Health Marijuana Therapeutic Research Project,

Trial A 1980-81," Department of Social Oncology, Evaluation Unit, Michigan Cancer Foundation (March 18, 1982).

Ungerleider, J., Andrysiak, T., Fairbanks, L., Goodnight, J., Sama, G. and Jamison, K. (1982). Cancer chemotherapy and marijuana.

Ungerleider, J., Andrysiak, T., Fairbanks, L., Goodnight, J., Sama, G. and Jamison, K. (1982). Cannabis and cancer chemotherapy: A comparison of oral delta-9-THC and prochlorperazine. Cancer, 50, 636-645.

Sensky, T., Baldwin, A., and Pettingale, K. (1983). Cannabinoids as antiemetics. Br. Med. J. , 286, 802.

Kutner, Michael H., Evaluation of the Use of Both Marijuana and THC in Cancer Patients for the Relief of Nausea and Vomiting Associated with Cancer Chemotherapy After Failure of Conventional Anti-Emetic Therapy: Efficacy and Toxicity" as prepared for the Composite State Board of Medical Examiners, Georgia Department of Health, by physicians and researchers at Emory University, Atlanta, (January 20, 1983).

Annual Report: Evaluation of Marijuana and Tetrahydrocannabinol in the Treatment of Nausea and/or Vomiting Associated with Cancer Therapy Unresponsive to Conventional Anti-Emetic Therapy: Efficacy and Toxicity," Board of Pharmacy, State of Tennessee, July 1983.

The Lynn Pierson Therapeutic Research Program," the Behavioral Health Sciences Division, Health and Environment Department, March 1983 and 1984.

Foltin, R.W., Brady, J.V. and Fischman, M.W. 1986. Behavioral analysis of marijuana effects on food intake in humans. Pharmacology, Biochemistry and Behavior. 25: 577-582.

Foltin, R.W. et al., 1988 Effects of Smoked Marijuana on Food Intake and Body Weight of Humans Living in a Residential Laboratory," Appetite 11:1-14

Vinciguerra, V., Moore, T., Brennab, E., Inhalation marijuana as an antiemetic for cancer chemotherapy, (Oct. 1988) N.Y. State J. Medicine, 525-527.

T.F. Plasse, R.W. Gorter, S.H. Krasnow, et al., 1991. Recent clinical experience with dronabinol. Pharmacology, Bichemistry and Behavior 40: 695-700.

Doblin, R., Kleiman, M., Marijuana as antiemetic medicine: A survey of oncologists' experiences and attitudes, (1991), J. Clin. Oncology, 9:7, 1314-1319.

Abrams, D. 1995, Marijuana, the AIDS Wasting Syndrome, and the U.S. Government (Response to Letter) New England Journal of Medicine, Vol. 333 (10): 670-671.

Grinspoon, L, J, and Doblin, R. 1995. Marijuana, the AIDS Wasting Syndrome, and the U.S. Government (Letter to ed.) New England Journal of Medicine, Vol. 333(10): 670-671.

Wesner, B. 1996. The Medical Marijuana Issue Among PWAs: Reports of Therapeutic Use and Attitudes Toward Legal Reform. Drug Research Unit, Social Science Research Institute, University of Hawaii at Manoa.

Medical Marijuana and Glaucoma

Hepler, R. and Frank, I., (1971). Marijuana smoking and intraocular pressure. JAMA, 217, 1932.

Hepler, R., Frank, I. and Ungerleider, J. (1972). Pupillary constriction after marijuana smoking. Am. J. Ophthalmol., 74, 1185-1190.

Shapiro, D. (1974). The ocular manifestations of the cannabinoids. Opthalmologica, 168, 366-369.

Hepler, R. and Petrus, R. (1976). Experiences with administration of marijuana to glaucoma. In The Therapeutic Potential of Marijuana. (Cohen and Stillman, eds.), 63-75.

Perez-Reyes, M., Wagner, D., Wall, M. and Davis, K. (1976). Intravenous administration of cannabinoids and intraocular pressure. In The Pharmacology of Marihuana (Braude and Szara, eds.), 829-832.

Goldberg, I., Kass, M. and Becker, B. (1978-1979). Marijuana as a treatment for glaucoma. Sightsaving Review, Winter issue, 147-154.

Crawford, W., and Merritt, J. (1979). Effects of tetrahydrocannabinol on arterial and intraocular hypertension. Int'l J. Clin. Pharmacol. and Biopharm. 17, 191-196.

Merritt, J., Crawford, W., Alexander, P., Anduze, A. and Gelbart, S. (1980). Effect of marihuana on intraocular and blood pressure in glaucoma.Ophthalmology, 87, 222-228.

Merritt, J., McKinnon, S., Armstrong, J., Hatem, G. and Reid, L. (1980). Oral delta-9-tetrahydrocannabinol in heterogenous glaucomas. Annals of Ophthalmology, 12, No. 8.

Zimmerman, T. (1980). Efficacy in glaucoma treatment-the potential of marijuana. Annals of Ophthalmology, 449-450.

Green, L., (1984) Marijuana effects on intraocular pressure, Applied, Pharmacology in the Medical Treatment of Glaucomas, (S.M. Drance, ed.), 507-526.

Merritt, J., et al. (1981). Effects of topical delta-9-tetrahydrocannabinol on intraocular pressure in dogs. Glaucoma, Jan./Feb., 13-16.

Merritt, J., Perry, D., Russell, D. and Jones, B. (1981). Topical delta-9-tetrahydrocannabinol and aqueous dynamics in glaucoma. J. Clin. Pharmacol., 21, 467S-471S.

Merritt, J., Olsen J., Armstrong, J. and McKinnon, S. (1981). Topical delta-9-tetrahydrocannabinol in hypertensive glaucomas. J. Phar. Pharmacol., 33, 40-41.

Merritt, J. (1982). Glaucoma, hypertension, and marijuana. J. Nat'l Med. Ass'n., 74, 715-716.

Merritt, J., Cook, C. and Davis, K. (1982). Orthostatic hypotension after delta-9- tetrahydrocannabinol marihuana inhalation. Ophthalmic Res., 14, 124-128.

Merritt, J. et al. (1982). Topical delta-8-tetrahydrocannabinol as a potential glaucoma agent. Glaucoma, 4 253-255.

Merritt, J. (1984). Outpatient cannabinoid therapy for heterogenous glaucomas: Guidelines for institution and maintenance of therapy. Marijuana 84: Proceedings of the Oxford Symposium on Cannabis, 681-683.

Merritt, J., Shrewsbury, R., Locklear F., Demby, K. and Wittle, G. (1986), Effects of delta-9-tetrahydrocannabinol and vehicle constituents on intraocular pressure in normotensive dogs. Research Communication in Substances of Abuse, 7, 29-35.

Medical Marijuana, Muscle Spasm and Convulsion

Carlini, E., Leite, J., Tannhauser, M. and Berardi, A. (1973). Cannabidiol and cannabis sativa extract protect mice and rats against convulsive agents. J. Pharm. Pharmac., 25, 664-665.

Karler, R., Cely, W., and Turkanis, S. (1973). The anticonvulsant activity of cannabidiol and cannabinol. Life Sciences, 13, 1527-1531.

Dunn, M. and Davis, R., (1974). The perceived effects of marijuana on spinal cord injured males, Paraplegia, 12, 175.

Turkanis, S., Cely, W., Olsen, D. and Karler, R. (1974). Anticonvulsant properties of cannabinol. Res. Comm. Chem. Path. Pharmacol., 8, 231-246.

Consroe, P., Wood, G., and Buchsbaum, H. (1975). Anticonvulsant nature of marijuana smoking. JAMA, 234, 306-307.

Karler, R. and Turkanis, S. 1976. The antiepileptic potential of the cannabinoids. In The Therapeutic Potential of Marijuana, (Cohen and Stillman, eds.), 383-396.

Feeney, D.M., Marihuana and epilepsy: paradoxical anticonvulsant and convulsant effects, Marijuana Biological Effects: Analysis, Metabolism, Cellular Responses, Reproduction and the Brain, (Nahas, GG., Paxton, M., Bruade, J.C., Hardillier, and Harvey, D.J. eds.) Pergamon Press, Oxford, England, 643-657.

Petro, D., (1980), Marihuana as a therapeutic agent for muscle spasm of spasticity, Psychosomatics, 21: 81, 85.

Cunha, J., et al. (1980). Chronic administration of cannabidiol to health volunteers and epileptic patients. Pharmacology, 21, 175-185.

Petro, D., Ellenberger, C., Jr., (1981). Treatment of human spasticity with delta-9- tetrahydrocannabinol, J. Clin. Pharmacol., 21:413S-416S.

Clifford, D.B.. 1983. Tetrahydrocannabinol for tremor in multiple sclerosis. Annals of Neurology. 13: 669-671.

Sandyk, R., Consroe, P., Stern, L., Snider, S., (1986). Effects of cannabidiol in Huntington's Disease, Neurology, 36:331.

Hanigan, W.C., Destree,R. and Truong, X.T., (Feb., 1986), The effect of delta-9- tetrahydrocannabinol on human spasticity, Clin. Pharmacol. Ther., 198. Truong, X.T.,

Hanigan, W.C., (Feb. 1986). Effect of delta-9-tetrahydrocannabinol on EMG measurements in human spasticity. Clin. Pharmacol. Ther., 232.

Cannabis, (1986) Therapeutic Claims in Multiple Sclerosis, Int'l Federation of Multiple Sclerosis Societies, 226.

Ames, F. and Cridland, S. (1986). Anticonvulsant effects of cannabidiol. S. Afr. Med. J., 69, 14.

Ungerleider, T. 1987.Delta 9 THC in treatment of spasticity associated with marijuana. Advances in Alcohol and Substance Abuse, 7: 39-51.

Meinck, H.M., Schonle, P.W., Conrad, B. 1989. Effect of Cannabinoids on Spasticity and Ataxia in multiple sclerosis. Journal of Neurology 236: 120-122.

Maurer, M., Henn, V., Dittrich A., Hoffamn, A., 1990. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. European Archives of Psychiatry and Clinical Neuroscience 240: 1-4.